Advisory Board

Sebastian Aguiar, MSc

Sebastian Aguiar, MSc is a geroscientist and Venture Fellow at Apollo Ventures. He believes that slowing and reversing the damage that causes aging will result in a medical paradigm shift equivalent to the advent of antibiotics.

Prior to Apollo, Sebastian was an Associate at Deep Knowledge Ventures in London, a Fulbright Research Fellow at the Telomere and Genomic Stability Laboratory of the Gulbenkian Institute, a VC finance research assistant at the California Institute of Technology (Caltech), and a SENS Research Scholar at the Buck Institute for Research on Aging.

Sebastian holds an MSc in Biomedical Science from the University of Amsterdam where he was an Amsterdam Excellence Scholar. He also holds an MSc in Life Science Business Management from the VU Amsterdam and received his B.A. with honors in Human Biology from Pitzer College, Claremont University Consortium.

His publications include RNAi mechanisms in Huntington’s disease therapy: siRNA versus shRNA, December 2017; Induced Cell Turnover: A Novel Therapeutic Modality for In Situ Tissue Regeneration, May 2017; and Neuropharmacological Review of the Nootropic Herb Bacopa monnieri, June 2013.

Visit his LinkedIn profile. Follow him on Twitterand on Facebook. Read his blog. Watch his TEDx talk.